37.40
+0.60
+(1.63%)
As of 8:30:12 PM GMT+2. Market Open.
Key Executives
Key Executives Information Not Available
Merus NV
Profile Information Not Available
Description
Description Information Not Available
Corporate Governance
Merus NV’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
May 6, 2025 at 10:59 AM UTC - May 12, 2025 at 12:00 PM UTC
Merus NV Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
ARDX.MX Ardelyx, Inc.
105.50
0.00%
RPD.MU Royalty Pharma plc
28.29
+0.32%
B9A.F BioArctic AB (publ)
15.00
-21.34%
PROT Proteonomix, Inc.
0.0000
0.00%
P0F.F Egetis Therapeutics AB (publ)
0.2835
-2.58%
HQ1.MU Oruka Therapeutics Inc. R
7.50
+2.04%
7PO.F Poxel S.A.
0.3805
-17.82%
2HA.F Spero Therapeutics, Inc.
0.6340
+0.16%
BT3.BE Lineage Cell Therapeutics Inc
0.3600
-1.10%
NMLSF Restart Life Sciences Corp.
0.0320
0.00%